Don't miss out on a sector that has $1.37 trillion in available capital for M&A!
The Investing News Network reached out to the market watchers and insiders to get their best predictions for 2024, including top stocks and trends to watch!
"There is every reason to expect biopharma dealmaking to continue and accelerate. Despite its increased dealmaking activity, the sector retains more than US$1.37 trillion in available capital for M&A."
Subin Baral
The Investing News Network is a growing network of authoritative publications delivering independent, unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety of markets including gold, battery metals, biotech and many others. This means you read nothing but the best from the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks of research yourself.
At the same time, not a single word of the content we choose for you is paid for by any company or investment advisor: We choose our content based solely on its informational and educational value to you, the investor.
So if you are looking for a way to diversify your portfolio amidst political and financial instability, this is the place to start. Right now.
Power your portfolio with the wisdom of and experience of the top pharma experts in the industry. Written for investors of all levels.
Copyright 2024 © Dig Media Inc.
Separate the signals from the noise. What are key trends that will really move the markets.
Always stay ahead of the markets by benefitting from the predictions of the best market experts in the industry.
From mega caps to hidden gems, let us help you find just the right stock to turbocharge your investment portfolio.
EY
![]() |
Pharma Market Forecast: 3 Top Trends That Will Affect Pharma in 2024
The pharmaceutical industry is a dynamic and complex sector that plays a vital role in healthcare. |
---|---|
![]() |
Top 5 NASDAQ Pharma Stocks
The industry's major underlying drivers — such as higher rates of cancer and chronic diseases — are still driving innovation in this sector.. |
![]() |
Top 3 Canadian Pharma Stocks
From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. |
INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled. The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available. Prior to making any investment decision, it is recommended that readers seek advice from a qualified investment advisor.